We also demonstrated that PHD inhibition activates apoptosis in AML cells harboring diverse genetic alterations, including MLL-AF9, which function upstream of Meis1 and Hoxa9, as well as AML-ETO, PML-RARα and FLT3-ITD (with and without NPM1 mutations). This evidence concerns the gene KMT2A and acute myeloid leukemia.